Basel Medical Group Ltd
BMGL
$0.61
$0.024.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.03M | -3.79M | 315.00K | 925.50K | 1.54M |
| Total Depreciation and Amortization | 891.90K | 670.20K | 460.80K | 427.30K | 392.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.83M | 3.65M | -380.50K | -223.30K | -65.10K |
| Change in Net Operating Assets | -3.74M | -2.61M | -1.50M | -757.30K | -1.60K |
| Cash from Operations | -3.05M | -2.08M | -1.10M | 372.10K | 1.86M |
| Capital Expenditure | -8.23M | -4.05M | -13.90K | -9.90K | -5.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00 | 20.80K | 41.00K | 20.60K | -- |
| Cash from Investing | -8.23M | -4.03M | 27.10K | 10.70K | -5.80K |
| Total Debt Issued | 14.70M | 10.04M | 5.39M | 3.40M | 1.42M |
| Total Debt Repaid | -9.69M | -8.24M | -6.78M | -4.85M | -2.92M |
| Issuance of Common Stock | 9.75M | 4.88M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.74M | 5.52M | 9.30M | 4.51M | -267.60K |
| Cash from Financing | 12.45M | 9.17M | 5.98M | 2.35M | -1.31M |
| Foreign Exchange rate Adjustments | -350.30K | -176.60K | -9.10K | -4.60K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 819.90K | 2.89M | 4.89M | 2.73M | 545.00K |